Terumo BCT has initiated the next phase of its business relationship with Therakos. Terumo will now be the exclusive distributor in Argentina, Chile, Colombia, Mexico, Uruguay and Peru of the Therakos Uvar XTS photopheresis system and the Therakos Cellex photopheresis system, which physicians use to treat patient with diseases of the immune system.
Through its relationship with Therakos, Terumo will be able to expand its product portfolio to provide customers with broader therapeutic products and protocols. Terumo BCT claims to be the leading supplier of apheresis technology in Latin America. This multi-year agreement will enable Terumo BCT to begin distributing Therakos products in April 2014 in Argentina, Chile, Colombia, Mexico, Uruguay, Peru, and in other countries pending regulatory clearance over the next several months. Terumo began distributing Therakos products in January 2014 in Australia and New Zealand.